This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fahr, M. J. Articles by Kumberg, V. S. Search for Related Content PubMed PubMed Citation Articles by Fahr, M. J. Articles by Kumberg, V. S. Social Bookmarking                         What's this?

Glutamine Enhances Immunoregulation of Tumor Growth

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock

Jacki Kornbluth, PHD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock

Sarah Blossom, BS

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock

Robert Schaeffer, MD

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock

V. Suzanne Kumberg, MD

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, Department of Pathology, University of Arkansas for Medical Sciences, Little Rock

Background: It is known that tumor progression is associated with a depletion in host glutamine (Gln) stores and a depression of natural killer (NK) cell activity. After demonstrating an in vitro dependence of NK cell activity on Gln and glutathione concentration, this study evaluated the effects of oral Gln on Gln and glutathione metabolism, NK cell activity, and tumor growth in the tumor-bearing rat. Methods: Two days before tumor implantation, rats (n = 32) were randomized to receive Gln (1 g/kg/d) or an isonitrogenous amount of glycine by gavage and pair-fed food. On day 21 after tumor implantation, rats were killed, and tumors were measured and processed for glutaminase activity, glutathione content, and tumor morphometrics. Splenic lymphocytes were assayed for NK cell activity via a chromium ( ⁵¹Cr) release assay using YAC (NK-cell-sensitive mouse tumor cell line) target cells. Blood Gln and glutathione were measured. A second set of rats (n = 16) were treated similarly except that ketamine was given twice weekly to suppress NK cell activity. Results: During the 3-week study period, tumor growth was decreased by 40% in the Gln group. This decrease in growth was associated with a 30% increase in NK cell activity. Administration of ketamine to rats completely reversed the higher NK cell activity and decreased the tumor growth seen in the Gln-treated group. Conclusions: These data indicate that oral Gln supplementation, through support of host Gln stores and glutathione production, may decrease tumor growth by enhancing NK cell activity. (Journal of Parenteral and Enteral Nutrition 18:471-476, 1994)

Journal of Parenteral and Enteral Nutrition, Vol. 18, No. 6, 471-476 (1994)
DOI: 10.1177/0148607194018006471


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W.-S. Wang, J.-K. Lin, T.-C. Lin, W.-S. Chen, J.-K. Jiang, H.-S. Wang, T.-J. Chiou, J.-H. Liu, C.-C. Yen, and P.-M. Chen Oral Glutamine Is Effective for Preventing Oxaliplatin-Induced Neuropathy in Colorectal Cancer Patients Oncologist, March 1, 2007; 12(3): 312 - 319. [Abstract] [Full Text] [PDF]

				M. F. McCarty and K. I. Block Toward a Core Nutraceutical Program for Cancer Management Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171. [Abstract] [PDF]

				V. S. Klimberg Is Glutamine Effective in Enhancing Host Immune Response to Tumors? J. Nutr., December 1, 2005; 135(12): 2920S - 2920S. [Full Text] [PDF]

				N. Hiscock and B. K. Pedersen Exercise-induced immunodepression- plasma glutamine is not the link J Appl Physiol, September 1, 2002; 93(3): 813 - 822. [Abstract] [Full Text] [PDF]

				K. Krzywkowski, E. W. Petersen, K. Ostrowski, J. H. Kristensen, J. Boza, and B. K. Pedersen Effect of glutamine supplementation on exercise-induced changes in lymphocyte function Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1259 - C1265. [Abstract] [Full Text] [PDF]

				M. A. Medina Glutamine and Cancer J. Nutr., September 1, 2001; 131(9): 2539S - 2542. [Abstract] [Full Text] [PDF]

				A. M. Easson, T. M. Pawlik, C. P. Fischer, J. L. Conroy, D. Sgroi, W. W. Souba, and B. P. Bode Tumor-influenced amino acid transport activities in zonal-enriched hepatocyte populations Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1209 - G1218. [Abstract] [Full Text] [PDF]

				Y. Cao, Z. Feng, A. Hoos, and V. S. Klimberg Glutamine Enhances Gut Glutathione Production JPEN J Parenter Enteral Nutr, July 1, 1998; 22(4): 224 - 227. [Abstract] [PDF]

				G. K. Savy Enteral Glutamine Supplementation: Clinical Review and Practical Guidelines Nutr Clin Pract, December 1, 1997; 12(6): 259 - 262. [Abstract] [PDF]

				L. D. Shewchuk, V. E. Baracos, and C. J. Field Dietary L-Glutamine Supplementation Reduces the Growth of the Morris Hepatoma 7777 in Exercise-Trained and Sedentary Rats J. Nutr., January 1, 1997; 127(1): 158 - 166. [Abstract] [Full Text]